But unlike liraglutide, it has not been approved as a weight loss treatment for overweight and obese individuals [32]
Heart failure therapy by GLP-1RAs Although a meta-analysis of large-scale clinical trials suggested that GLP-1RAs reduce heart failure hospitalizations (HHF) by approximately 10% in patients with diabetes at high cardiovascular risk [22, 23], the treatment effects on the risk of HHF in individual trials other than AMPLITUDE-O were not significant (Tables 1, 2)
But based on what I am seeing clinically and what the latest research is showing, there are actually five distinct pathways
These injectable weight loss drugs including Ozempic, Saxenda, Wegovy and Mounjaro mimic the bodys GLP-1 hormone which is naturally released when we eat
BMC Surgery
As with any drugs, some people experienced side effects, including stomach trouble, aching joints, and low blood pressure, but they were infrequent and relatively mild